Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. The company is headquartered in Tucson, Arizona and currently employs 75 full-time employees. The company went IPO on 2025-08-29. SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
The most recent EPS for Picard Medical Inc is $, expectations of $.
How did Picard Medical Inc PMI's revenue perform in the last quarter?
Picard Medical Inc revenue for the last quarter is $
What is the revenue estimate for Picard Medical Inc?
According to of Wall street analyst, the revenue estimate of Picard Medical Inc range from $ to $
What's the earning quality score for Picard Medical Inc?
Picard Medical Inc has a earning quality score of B+/51.545002. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Picard Medical Inc report earnings?
Picard Medical Inc next earnings report is expected in 2026-06-23
What are Picard Medical Inc's expected earnings?
Picard Medical Inc expected earnings is $, according to wall-street analysts.
Did Picard Medical Inc beat earnings expectations?
Picard Medical Inc recent earnings of $ expectations.